Chang GC - Search Results

1

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.

Chang GC, Yang TY, Chen KC, Yin MC, Wang RC, Lin YC. Chang GC, et al. J Clin Oncol. 2004 Nov 15;22(22):4646-8. doi: 10.1200/JCO.2004.02.168. J Clin Oncol. 2004. PMID: 15542815 No abstract available.

2

Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cancer receiving cisplatin-based chemotherapy.

Chang GC, Yang TY, Shih CM, Lin LY, Lee HS, Chiang CD. Chang GC, et al. J Formos Med Assoc. 2003 Apr;102(4):257-61. J Formos Med Assoc. 2003. PMID: 12833190

3

Successful treatment of multifocal bronchioloalveolar cell carcinoma with ZD1839 (Iressa) in two patients.

Chang GC, Yang TY, Wang NS, Huang CM, Chiang CD. Chang GC, et al. J Formos Med Assoc. 2003 Jun;102(6):407-11. J Formos Med Assoc. 2003. PMID: 12923594

4

The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures.

Chang GC, Wu CL, Pan SH, Yang TY, Chin CS, Yang YC, Chiang CD. Chang GC, et al. Chest. 2004 Feb;125(2):541-7. doi: 10.1378/chest.125.2.541. Chest. 2004. PMID: 14769736

5

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status.

Chang GC, Chen KC, Yang TY, Yin MC, Lin CP, Kuo BI, Hsu JY. Chang GC, et al. Invest New Drugs. 2005 Jan;23(1):73-7. doi: 10.1023/B:DRUG.0000047108.39129.7c. Invest New Drugs. 2005. PMID: 15528983

6

Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines.

Chang JT, Chang GC, Ko JL, Liao HY, Liu HJ, Chen CC, Su JM, Lee H, Sheu GT. Chang JT, et al. Among authors: chang gc. Int J Cancer. 2006 Jan 15;118(2):317-25. doi: 10.1002/ijc.21372. Int J Cancer. 2006. PMID: 16080190

7

Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.

Paz-Ares L, Douillard JY, Koralewski P, Manegold C, Smit EF, Reyes JM, Chang GC, John WJ, Peterson PM, Obasaju CK, Lahn M, Gandara DR. Paz-Ares L, et al. Among authors: chang gc. J Clin Oncol. 2006 Mar 20;24(9):1428-34. doi: 10.1200/JCO.2005.04.3299. J Clin Oncol. 2006. PMID: 16549837 Clinical Trial.

8

Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.

Yang CH, Shih JY, Chen KC, Yu CJ, Yang TY, Lin CP, Su WP, Gow CH, Hsu C, Chang GC, Yang PC. Yang CH, et al. Among authors: chang gc. Cancer. 2006 Oct 15;107(8):1873-82. doi: 10.1002/cncr.22220. Cancer. 2006. PMID: 16989002 Free article.

9

Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J, Shih NY. Chang GC, et al. Clin Cancer Res. 2006 Oct 1;12(19):5746-54. doi: 10.1158/1078-0432.CCR-06-0324. Clin Cancer Res. 2006. PMID: 17020980

10

Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan.

Perng RP, Chen CY, Chang GC, Hsia TC, Hsu NY, Tsai YH, Tsai CM, Yang CH, Chen YM, Yu CJ, Lee JJ, Hsu HS, Yu CT, Kao EL, Chiu CH. Perng RP, et al. Among authors: chang gc. Jpn J Clin Oncol. 2007 Jan;37(1):9-15. doi: 10.1093/jjco/hyl119. Epub 2006 Dec 1. Jpn J Clin Oncol. 2007. PMID: 17142253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters